Moreover, LNP-mediated delivery of the bsAb mRNA exhibits a robust antitumor effect against multiple HER2-positive tumor cells and induces higher levels of IFN-λ and granzyme B than the direct application of the bsAb. Here, GZMB is linked to neoplasm.